US 8597946
Enhanced dendritic cells for cancer immunotherapy
granted A61KA61K40/19A61K40/24
Quick answer
US patent 8597946 (Enhanced dendritic cells for cancer immunotherapy) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K40/19, A61K40/24, A61K40/428, A61P